In conclusion, in this study we provide additional evidence that HDAC3 could also be a potential drug target for preserving pancreatic beta cells against apoptosis induced by lipotoxicity in type 2 diabetes. This evidence concerns the gene HDAC3 and type 2 diabetes mellitus.